Azenta Inc
For the period ended Sep 30, 2024. Filed Nov 27, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Nov 27, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Our corporate headquarters are currently located in Burlington, Massachusetts. We maintained the following principal facilities as of September 30, 2024:
| Square Footage · Ownership Status/ | ||||
|---|---|---|---|---|
| Location | Functions | Segment | (Approx.) | Lease Expiration |
| Suzhou, China | Laboratory & office | Multiomics | 240,000 | Owned |
| Hosingen, Luxembourg | B Medical headquarters & manufacturing | B Medical Systems | 228,000 | Owned |
| Indianapolis, Indiana | Sample storage, sales & support | Sample Management Solutions | 116,700 | September 2043 |
| Billerica, Massachusetts | Sample storage, R&D and office | Sample Management Solutions | 39,900 | October 2033 |
| South Plainfield, New Jersey | Laboratory and office | Multiomics | 73,300 | January 2030 |
| Plainfield, Indiana | Manufacturing, R&D and sales & support | Sample Management Solutions | 67,900 | August 2042 |
| Springfield, Missouri | Manufacturing, R&D and sales & support | Sample Management Solutions | 50,100 | December 2028 |
| Manchester, United Kingdom | Manufacturing and office | Sample Management Solutions | 44,700 | December 2029 |
| Burlington, Massachusetts | Corporate headquarters, training, R&D and sales & support | All | 26,200 | October 2025 |
In addition to the principal facilities listed above, we maintain additional laboratories, biorepositories, and sales and support offices throughout North America, Europe, and Asia. The Company believes that its facilities are in good physical condition, are suitable and adequate for the operations conducted at those facilities and are generally fully utilized and operating at normal capacity.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.